Radnostix INIS
OTC INIS
$0.05 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Radnostix (INIS) Non-Current Deffered Revenue (2018 - 2019)

Updated

Radnostix (INIS) reported Non-Current Deffered Revenue of $7,500 for Q3 2019, unchanged from the prior quarter.

Analysis

Radnostix (INIS) Non-Current Deffered Revenue (2018 - 2019) Analysis & Trends

Dating back to Q4 2018, Radnostix's Non-Current Deffered Revenue record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q3 2019 came in at $7,500 (Q2 2019), $7,500 (Q1 2019) and $7,500 (Q4 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn -
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn -
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Radnostix 23.81 Mn 17.92 Mn 1.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 7,500.00
Jun 30, 2019 7,500.00
Mar 31, 2019 7,500.00
Dec 31, 2018 7,500.00
API Access

Radnostix Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=INIS&period=max&api_key=YOUR_API_KEY